Fingerprint
Dive into the research topics of 'Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically